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SUMMARY 
Platelet MAO activity was estimated in 60 male drug free schizophrenics, 36 male drug free manics and 30 male 
normal healthy controls by Radio Isotopic Technique using C Tryptamine Bisuccinate as substrate. There was no 
significant difference between the enzyme activity in the schizophrenic, manic and control groups. Platelet MAO acti-
vity in the disorganized catatonic and paranoid schizophrenics was significantly lower as compared to the enzyme acti-
vity in the manic and healthy control group. Platelet MAO activity appears to be related to subgroups of schizophre-
nia disorganized, catatonic and paranoid. Limitations and scope for future research have been outlined. 
A consistent biological marker for 
schizophrenia would be welcome because it 
could serve as a validating criterion in 
sorting out the diagnostic puzzle surro-
unding this disease. Reduced platelet mo-
noamine oxidase (MAO) activity has been 
felt to be a possible 'genetic' marker for 
schizophrenia because of the results of a 
study (Wyatt et al., 1973) on monozygotic 
twins discordant for schizophrenia. This 
study found that both the schizophrenic twin 
and his healthy co-twin had reduced platelet 
MAO activity indicating that the finding 
was not due to hospitalization, psychoactive 
drugs or other secondary effects of the ill-
ness. This study stimulated much subse-
quent work. Whilst many studies (Berger et 
al., 1978; Wyatt et al., 1978; Potkin et al., 
1978; Sen Gupta et al., 1981) have replicated 
the above findings, some others (Broc-
kington et al., 1976; Gupta et al., 1985) have 
not. Many potential sources of variability 
could have accounted for the discrepancy in 
the findings of previous authors. In view of 
the wide differences in the findings re-
ported, attempts have been made to deter-
mine whether decreased platelet MAO acti-
vity is related to any subgroup of schizo-
phrenia. 
Acute schizophrenia as a group was not 
found to differ from control subjects 
(Friedman et al., 1974; Carpenter et al., 
1975). Meltzer and Stahl (1974) observed 
decreased MAO activity in acute schizo-
phrenics only when octapine and trypta-
mine were used as substrates, otherwise they 
had normal enzyme activity. Platelet MAO 
activity was lowered in schizophrenics 
which was more marked in chronic then in 
acute cases (Zeller & Davis, 1980). Paranoid 
schizophrenics have been reported in many 
studies, to have lowered platelet MAO 
activity (Potkin et al., 1978; Schildkraut et 
al., 1976; Van Valkenburg k Growe, 1978) 
however Berger et al., (1978), Gupta et al., 
(1985) could not confirm it. Auditory 
hallucinations have been observed to be 
associated with low platelet MAO activity in 
schizophrenic patients (Schildkraut et al., 
1976). Although this could not be replicated 
subsequently (Gupta et al., 1985). A positive 
relationship with global prognostic score 
and platelet MAO activity has been re-
ported (Gruen et al., 1982). Schizophrenics 
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with positive symptoms (thought disorder, 
hallucination or delusion) did not differ 
from patients with negative symptoms 
(flattening of affect and mutism) (Broc-
kington et al., 1976). 
A neglected and poorly understood 
aspect of psychiatric correlates of psy-
chiatric disorders is that not only low but 
also high platelet MAO activity appears to 
be related to psychopathology (Schalling et 
al., 1987). Another important observation 
has been that a small percentage of 'normal 
controls' have low MAO levels, well below 
the mean of the patient group (Buchsbaum 
et al., 1976). Furthermore, recent findings 
suggest that very low or very high platelet 
activity is associated with personality pro-
files linked with vulnerability to various 
psychiatric disorders. The intermediate 
group, on the other hand, is associated with 
higher scores on conformity scales and lo-
wer scores on anxiety and hostility scales 
and is presumably 'more normal' (Schalling 
et al., 1987). It is regretable that previous 
studies have not paid attention to this aspect 
while selecting controls. 
It is apparent that more investigations 
are required in schizophrenics with better 
control of several variables, to identify the 
subgroup of schizophrenics with altered 
MAO activity and what, if any, physiologi-
cal significance this might have. The present 
study was undertaken with the following 
aims: 
1 To study and compare platelet MAO 
activity in schizophrenics with that in 
-manics and control subjects. 
2. To find out whether platelet MAO 
activity is related to any subgroup of 
schizophrenia. 
Material & Methods 
Sixty male schizophrenics diagnosed as 
per DSM-III (American Psychiatric Associ-
ation, J980) between 16-50 years of age were 
selected from the out patient psychiatric 
section of the University Hospital, BrH.U., 
Varanasi. These patients had not received 
any drugs in the past 2 weeks, no electrocon-
vulsive therapy in the past 6 months,, had no 
history of alcohol or drug abuse in the past 6 
months, had no evidence of an organic men-
tal disorder or a physical illness requiring 
medication or anaemia with Hb < 10 gni%, 
and did not have past or family history, in 
first degree relatives, of an affective or 
schizo affective illness. 
Thirty six male manics (psychotic con-
trols) diagnosed as per DSM-III, matched 
with the schizophrenic group with regard to 
age and haemoglobin, were selected from 
the out-patient psychiatric section of the 
University Hospital B.H.U. These patients 
had not received any medication (inclu-
ding neuroleptic and lithium) in the past 2 
weeks, no electroconvulsive therapy in the 
past 6 months, had no history of alcohol or 
drug abuse in the past 6 months, had no 
evidence of an organic mental disorder or a 
physical illness requireing medication and 
did not have a past or family history in first 
degree relatives of a schizophrenic or a schi-
zoaffective'illness. 
Thirty male normal healthy donors 
(normal controls), matched with the pati-
ent group with regard to'age and haemo-
globin were selected from the blood donors 
attending the Blood Bank of the University 
Hospital, B.H.U. These subjects did not 
have any evidence of a physical illness 
requiring medication, history of a neuro-
psychiatric illness (Migraine, Hunting-
ton's chorea. Schizophrenia, Affective Dis-
order, Schizo-affective disorders etc.) in the 
subject or his first degree relatives or a his-
tory of alcohol or drug abuse in the past 6 
months. 
Procedure: 
The patients were hospitalized and kept 
drug free. They were evaluated on a struc-
tured profornia which included details of 
psychiatric history and mental status and 
physical cxamintion. 20 ml of fasting venous 
blood was collected between 9-11 A.M. 326  I. SHARMA tt Ml 
through vene puncture in heparan ized 
polypropylene tubes, from each subject, and 
immediately placed in ice. Platelet rich 
plasma (PRP) was prepared within 3 hours 
by sequential centrifugation of the sample at 
175,000 and 600g for 10 minutes each at 4°C 
and supernatant PRP obtained, after each 
centrifugation was pooled. Subsequently, 
the PRP was -centrifuged at 3000g for 5 
minutes to obtain platelet pellets. Platelet 
pellets were stored at 80 C till the time of 
assay, but never for more than one week. 
Platelet protein was estimated by Lowry's 
Method (Lowry et al., 1951). Finally, MAO 
activity was estimated by Radio Isotopic 
Technique, using C Tryptamine 
Bisuccinate as the substrate,. All esti-
mations were done in duplicate and the 
mean taken. Platelet MAO activity was ex-
pressed in micromoles of substrate per milli-
gram of protein per hour. Estimators were 
blind to the identity of the samples. Method 
and sample variation (calculated as the 
difference between the paired samples 
divided by the mean) was ±5% for duplicate 
samples from the same blood specimen and 
±16% when 2 blood samples were obtained 
from 15 healthy controls at an interval of one 
week. The coefficient of variation was 4% for 
duplicate samples from the same blood 
specimen and 9% for blood samples taken 
one week apart. 
Platelet MAO activity in the healthy 
control group ranged from 9.5-0.5 n niol/mg 
protein/h. The subjects with platelet MAO 
in the upper and lower decile were excluded 
as recent work has suggested that it is the 
intermediate group which is presumably 
more normal (Schalling et al., 1987). Thus 26 
healthy controls were available for final 
analysis. The data was analysed by Chi 
square test, analysis of variance, student 't' 
test and least significant difference 
(multiple Y test). 
Results 
There was no significant difference 
between the schizophrenic, manic and heal-
thy control groups with regard to age and 
haemoglobin (Table-I). 
No significant difference was observed 
between the platelet MAO activity in the 
schizophrenic, manic and healthy control 
groups (Table-II) 
Subcategorisation of schizophrenics was 
done according to DSM-III. Platelet MAO 
activity in the disorganised, catatonic and 
paranoid schizophrenics was significantly 
lower as compared to the enzyme activity in 
the manic and healthy control groups 
(Table-Ill). 
TABLE-1 Sample Characteristics 
Variables Schizo. Manics Controls 
(N=60) (N=36) (N=26) 
Age (in yrs.) 
16-25 29(48.4) 17(47.2) 13(50.0) 
26-35 8(38.3) 13(36.1) 10(38.5) 
36-50 8(13.3) 6(16.6) 3(11.5) 
X
2=0.38, d.f.=4, N.S. 
Hb(ingm%) 
12-13 14(23u3) 9(25.0) 7(26.9) 
13-14 38(63.3) 23(63.9) 15(57.7) 
14-15 8(13.3) 4(11.1) 4(15.4) 
X
2=0.13, d.f.=4, M.S. 
Figures in parenthesis indicate percentage 
TABLE-2 Platelet MAO Activity (in n mol/mgprotienlh) in 
various groups 
Mean s.cl. 
Schizo(n=60) 3.40 2.06 
Manics (n=36) 3.77 2.68 
Controls (n=26) 4.06 1.16 
F=0.967, N.S. PLATELET MAO ACTIVITY IN SUBGROUPS OF SCHIZOPHRENU 327 
TABLES Platelet MAO Activity (in n mol/mgprotein/h) in 
subtypes of schizophrenics, mania and controk 




















F=3.09, p <.05, LSD=1.038 
10 schizophrenics had received neu-
roleptic drugs for variable periods (3 
months — lMz years)., but were drug free at 
the time of inclusion in the study. No sig-
nificant difference was found between the 
platelet MAO activity of treated and nevei 
treated schizophrenics and controls (t=0.73; 
d.i.=58;p<0.5). 
Discussion 
The present study was conducted on 60 
schizophrenics, 36 manics (psychotic con-
trols) and 30 normal healthy controls in 
which platelet MAO activity was deter-
mined by Radio Isotopic Technique using 
C Tryptamine Bisuccinate as the substrate. 
Special care was taken to control the vari-
ables that might be related to platelet MAO 
activity. 
No significant difference in the platelet 
MAO activity was observed between the 
patient group (schizophrenics) and the two 
control groups (manics and healthy con-
trols). These observations are in confor-
mity with the earlier reports (Brockington et 
al., 1976; Gupta et al., 1985). Some studies 
(Brockington et al., 1976; Berger et al., 1978; 
Wyatt et al., 1978; Sen Gupta et al., 1981) 
however, have reported a significant reduc-
tion in platelet MAO activity in chronic 
schizophrenics. Many potential sources of 
variability could have accounted for the 
discrepancy in the findings of previous 
authors. An important source of variance 
lies in the distribution of subgroups of 
schizophrenics in different populations. An 
attempt was made to find out whether the 
decrease in MAO activity was related to any 
subgroup of schizophrenia. It was observed 
that the disorganized, catatonic and- para-
noid subgroups of schizophrenia had sig-
nificantly lower platelet MAO activity as 
compared to undifferentiated schizo-
phrenics, manics and healthy controls. 
Normal activity in the manic group suggest 
that the lowered enzyme activity observed is 
not a non-specific change, but rather specific 
for certain subcategories of schizophrenia. 
However, since the number of patients in 
these subgroups was small* the conclusions 
can be regarded as only tentative. 
Platelet MAO activity was estimated.,in 
16 paranoid and 19 chronic hebephrenic 
schizophrenics by Flurometric method 
using Kynuramine as substrate and was ob 
served to be significantly reduced as com-
pared to controls (Van Valkenburg and 
Crowe, 1978). 
In several studies (Potkin et al., 1978; 
Schildkraut et al., 1976; Van Valkenburg 
and Corwe, 1978) an association between low 
platelet MAO activity and paranoid 
symptoms has also been reported. In a 
mixed group of schizophrenics, patients 
with persecutory and accusatory delusions 
and auditory hallucination had signi-
ficantly lower platelet MAO activity than 
others who did not have these symptoms 
(Schildkraut et al., 1978). Retrospective and 
prospective studies conducted by Potkin 
and associates confirmed the association of 
low MAO, activity with the paranoid 
subgroup (Potkin et al., 1978). 
In some studies, howver, (Gupta et al., 
1986) lowered platelet MAO activity in the 
paranoid subgroup could not be demons-
trated. Why one paranoid group should 
differ from another is not immediately 328  1. SHARMA it al 
apparent. The discrepant findings were 
possibly because of heterogenous diag-
nostic criteria and use of different substrate 
and techniques for MAO estimation. Studies 
which failed to demonstrate low platelet 
MAO activity may have included patients 
with relatively better prognosis, since 
platelet MAO activity in schizophrenics has 
been observed to correlate with global 
prognostic score (Gruen et al., 1982). Gupta 
and co-workers (1985) estimated platelet 
MAO activity by spcctrophotometric 
method which was not sensitive enough to 
tap very low levels of MAO activity. They 
did not observe any enzyme activity in 4 
patients (13%), 4 first degree relatives (13%) 
and one control (0.33%) and excluded these 
subjects from statistical analysis, which may 
have confounded the results. Besides, they 
did not collect fasting samples which is 
necessary since blood glucose levels have 
been found to correlate with platelet MAO 
activity (Demishch et al., 1979). 
The present work suggests that some 
form of schizophrenia (disorganised, cata-
tonic and paranoid schizophrenia) may be 
separate from other forms of schizophrenia 
and this difference may be related, at least in 
part, to biochemical characteristics. 
Some-of the limitations of the present 
investigation need to be mentioned. The 
study should be replicated in the different 
subgroups of schizophrenia with larger 
number of patients and controls. It would be 
necessary to undertake similar work on fe-
male subjects, taking measures to control for 
the phases of menstrual cycle because 
platelet MAO activity has been reported to 
be higher in females and to fluctuate during 
the pre and post ovulatory phase (Wyatt et 
al., 1979). Simultaneous processing of con-
trol and patient samples has been sugges-
ted since relatively minor changes in the 
procedure can markedly influence platelet 
yield and leucocyte contamination (White et 
al., 1976). This was not done in the present 
study because of practical difficulties. 
The decrease in platelet MAO activity 
could be related to the cause of the illness or 
could simply be associated with the disor-
der. A causal relationship could be particu-
larly exciting because many biogenic amine 
hypothesis of schizophrenia (the dopamine, 
transmethylation, phenylethylamine and 
norepinephirie hypothesis) would be con-
sistent with decrease in MAO activity (Wyatt 
et al., 1979). However, only an association 
has been established so far. Further research 
based on the 'Biochemical High Risk 
Paradigm' shall throw more light by tra-; 
nscending the dilemma of whether the bio-
logical abnormality observed is of etiolo-
gical significance or the result of the 
disorder. 
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